Seeing big nerves in small children Despite being a literally palpable clinical feature of some peripheral neuropathies, nerve enlargement is rarely studied systematically. Enlarged nerves can often be felt or seen, particularly in the neck, in the hereditary hypertrophic neuropathies, especially in Dejerine-Sottas disease and Charcot-Marie-Tooth disease type 1A (CMT1A). Even in affected children as young as 3 years, the authors have strongly suspected CMT1A when the child, and particularly a parent, has excessively large and easily palpable median nerves at the elbow, which approach or exceed the size of a standard pencil. Nerve hypertrophy is also encountered in Hansen disease, chronic inflammatory demyelinating neuropathy, nerve tumors, and certain focal nerve lesions. For the first time, Yiu et al. 1 have provided an analytical description of its distribution, evolution, and functional significance in children. Why has this taken so long? Unlike disease in other organs, disease in nerve and muscle has only been studied with the microscopevirtually never with the naked eye. Barring abscess or tumor, nerves and muscles are cut away at autopsy and most pathologists see nothing but tiny fragments from clinical donors. Even in the virtual world of MRI, most radiologists look past the nerves and muscles to seek out disease in other organs. However, placing high-resolution ultrasound in the hands of enterprising investigators such as Yiu et al. has for the first time made it possible not just to recognize nerve enlargement, but to measure it.
What did they find? They discovered that nerve enlargement occurs early in the course of CMT1A. Based on prior pathologic studies, it is unlikely that this is simply the result of onion bulb formation, a chronic process that takes many years to develop. Furthermore, they found that the enlargement tends to be proximal, a finding somewhat unexpected in generalized neuropathies where pathology tends to manifest distally.
Is the enlargement functionally significant? It seems likely; nerve conduction velocities and amplitudes show impairments in very young children, more or less inversely proportional to the degree of nerve enlargement. 2 More difficult to address is the prognostic relevance of nerve enlargement. This study shows that nerves enlarge over time both in healthy controls and patients, so, even if a longitudinal study was conducted, it might be difficult to separate out the effects of growth and years of exposure to a genetic disorder. Does nerve enlargement in adults with CMT1A show a similar proximal predilection? The evidence, though limited, suggests it does. [3] [4] [5] Why is this? The authors suggest the possibility of deposition of collagen in nerves, 6 but in lieu of tissuebased studies, it is difficult to know for sure. Clearly, future research is needed.
Why are these findings important? The first is that nerve enlargement appears to be an early occurrence, and perhaps a biomarker in CMT1A, which can be assessed reliably, painlessly, quickly, and at low cost with neuromuscular ultrasound. Second, although not explored in this study, ultrasound has the potential to provide additional information in CMT1A both about muscle atrophy/fibrosis and about nerve blood flow using color flow Doppler or contrast agents. 7, 8 Third, serial studies with ultrasound are easily performed and are ideal for longitudinal studies. Fourth, individuals with CMT1A are particularly vulnerable to certain neurotoxic medications, particularly vincristine, and having an immediate noninvasive way to screen for someone affected may help prevent a rare but crippling iatrogenic catastrophe. 9 Fifth, and perhaps most important, this article highlights the use of ultrasound in children with neuromuscular disease. Because parents or pediatricians may view electrodiagnostic studies as too painful, sometimes children are denied neuromuscular testing, a benefit routinely granted to adults. MRI, histopathology, serology, genetic testing, and electrodiagnosis are all valuable tools in the evaluation of children with neuromuscular diseases, but sometimes ultrasound may be an attractive initial modality for screening and directing subsequent tests.
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